Daily Peptide Briefing

Dose-Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study.

The lancet. Diabetes & endocrinology

Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study.

The lancet. Diabetes & endocrinology

Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.

Lancet (London, England)

A subphenotype of obesity with reduced enteroendocrine GLP-1 synthesis and enhanced tirzepatide response.

Gastroenterology

Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like-Peptide-1 Use Following 10-Session Cognitive-Behavioural Therapy for Binge-Eating Disorder: A Single-Case Experimental Design.

European eating disorders review : the journal of the Eating Disorders Association

Use of second-generation incretin analogs (GLP-1 and GIP receptor agonists) in type 1 diabetes and latent autoimmune diabetes in adults: A systematic review.

Journal of the American Association of Nurse Practitioners

Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes.

Dermatology and therapy

🚨 For those interested in PEPTIDES please read up: My goal is to TRAIN and EDUCATE as many medical professionals about the proper use of peptides over the next 5 years. I’m working behind the scenes on the legal and FDA-related availability but IMO that’s an inevitability. https://t.co/uo0l4QBLg9

The peptides with the most human clinical data, listed. Not results. Not anecdotes. Strictly human trial evidence. 1.Semaglutide (the “OG” GLP-1) GLP-1 receptor agonist. Quiets food noise, slows gastric emptying, drives significant weight loss. 2.Tirzepatide (the upgrade)

You already take a peptide, or know someone who does. Ozempic is a peptide. So is insulin. A peptide is just a short chain of amino acids, smaller than a protein, that the body uses to send signals. That one word now covers two very different worlds. On one side: more than two https://t.co/hwfSOZtleR

Most people still don't know there's an FDA approved GLP-1 pill for weight loss that requires no injection and no fasting, and the ones who do know are ignoring it for one reason, Because it's not a peptide. Foundayo, the brand name for orforglipron, was approved by the FDA in

Tadalafil users Airlines lost my bag, inside were my a few of my daily stack including; Tadalafil, Semaglutide & Tirzepatide, BPC-157, Thymosin Beta-4, CJC-1295 & Ipamorelin, Epithalon, GHK-Cu, Semax & Selank and DSIP. Luckily I still have most of my others. What do I do?

1/ The word “peptide” has become almost meaningless on social media. Some peptides have decades of human data, known receptors, and FDA approval. Others are supported primarily by animal studies, mechanistic theories, and anecdotes. The most important takeaway from Dr. Abud https://t.co/VlySymIWg7

🚀 New Peptide Lineup Coming Soon We’ve locked in our first inventory run and are building a full stack of research peptides. GLP‑1 / Metabolic Peptides - Retatrutide (Reta) – 10 mg, 20 mg, 30 mg - Tirzepatide – 10 mg - Semaglutide – 5 mg, 10 mg Recovery / “Wolverine”

Sources, so you can grade these yourself. Ranked by tier. APPROVED PEPTIDE DRUGS (real human RCTs, tested in thousands): Insulin, the original peptide drug (clinical use since 1922). DCCT/EDIC: intensive therapy cut cardiovascular events 42% at 17-year follow-up (the effect